Libby Chatwin is one of the more than 100,000 medical cannabis card holders in Utah, a new record for the program.

Instead, we have the opportunity to chart a new course that protects public health and benefits Pennsylvanians whether they ...

Beacon Securities analyst Russell Stanley reiterated his “Buy” rating and C$11.00 price target in a May 8 note.

GrowGeneration trades at a deep discount to book value with no debt and strong cash reserves, offering upside. See why GRWG ...

House Democrats push through a bill to legalize marijuana in Pennsylvania. It now goes to the Republican-controlled state ...

Once considered a darling of the cannabis sector, shares of Tilray Brands TLRY have steadily declined over the past few years ...

And again, I think we've got to kind of chart that out over the next, call it, three to six months. But, look, I mean, Florida has we have over 21 million residents, and as cannabis becomes more ...

Data: U Miss, NIDA Potency Monitoring Project via NIH; Chart ... A Social History of Marijuana." "That's not the way to judge the plant." And THC levels aren't limited to what can be produced ...

Organigram’s growth is nothing to weed out, says Haywood Capital Markets’s analyst Neal Gilmer, who’s holding firm on his ...

Vaillancourt R, Gallagher S, Cameron JD, Dhalla R. Cannabis use in patients with insomnia and sleep disorders: Retrospective chart review. Can Pharm J (Ott). 2022 Apr 15;155(3):175-180.

The greater degree of control over integrating its equipment and processes also improved its pricing power, margins, and customer switching costs. We expect Chart will produce $4.74 billion in 2025 ...